Kirsten Van Hoorde

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study

Ben Van Calster, Kirsten Van Hoorde, L. Valentin et al. · BMJ · 2014 · 482 citations · Full text

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors.

Ben Van Calster, Kirsten Van Hoorde, Wouter Froyman et al. · PubMed · 2015 · 104 citations · Full text

Practical Guidance, Cancer Management, Pathology +17

A spline-based tool to assess and visualize the calibration of multiclass risk predictions

Kirsten Van Hoorde, Sabine Van Huffel, D. Timmerman et al. · Journal of Biomedical Informatics · 2015 · 83 citations · Full text

Risk Assessment, Classification Method, Engineering +11

Managing pregnancy of unknown location based on initial serum progesterone and serial serum hCG levels: development and validation of a two‐step triage protocol

Ben Van Calster, S. Bobdiwala, Sharmistha Guha et al. · Ultrasound in Obstetrics and Gynecology · 2016 · 78 citations · Full text

Rationalizing the management of pregnancies of unknown location: temporal and external validation of a risk prediction model on 1962 pregnancies

Ben Van Calster, Y. Abdallah, Sharmistha Guha et al. · Human Reproduction · 2013 · 77 citations · Full text